Indian generics producers, access to essential medicines and local production in Africa: An argument with reference to Tanzania

European Journal of Development Research

Volumn 22, Issue 4, 2010, Pages 451-468

  Chaudhuri, Sudip ^a   MacKintosh, Maureen ^b   Mujinja, Phares G M ^c  

^a INDIAN INSTITUTE OF MANAGEMENT CALCUTTA   (India)

^b OPEN UNIVERSITY   (United Kingdom)

^c MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

access to medicines; Indian pharmaceutical exports; industrial policy; local pharmaceutical production; Tanzania

Indexed keywords

INDUSTRIAL POLICY; INDUSTRIAL PRODUCTION; LEGISLATION; MEDICINE; PHARMACEUTICAL INDUSTRY; POLICY MAKING; PUBLIC GOODS; REGULATORY FRAMEWORK;

TANZANIA;

EID: 77956166582     PISSN: 09578811     EISSN: 17439728     Source Type: Journal    
DOI: 10.1057/ejdr.2010.27     Document Type: Article

References (30)

1. Amsden, A.H. (1989) Asia's Next Giant: South Korea and Late Industrialization. New York: Oxford University Press.
2. Balance, R., Pogany, J. and Forstner, H. (1992) The World's Pharmaceutical Industries: An International Perspective on Innovation, Competition and Policy. Basingstoke, UK: Edward Elgar.
3. Bate, R. (2008) Local Pharmaceutical Production in Developing Countries: How Economic Protectionism Undermines Access to Quality Medicines. London: International Policy Network, http://www.fightingdiseases.org/pdf/local-drug- production.pdf, accessed 30 March 2009.
4. Bate, R., Coticelli, P., Tren, R. and Attaran, A. (2008) Antimalarial drug quality in the most severely malarious parts of Africa-A six country study. PLoS ONE 3(5), http://www.plosone.org.
5. Bhattacharjea, A. (2002) Infant industry protection revisited: Entry deterrence and entry promotion when a foreign monopolist has unknown costs. International Economic Journal 16(3): 115-133.
6. Center for Pharmaceutical Management. (2003) Access to Essential Medicines: Tanzania, 2001. Arlington, VA: Center for Pharmaceutical Management, Management Sciences for Health.
7. Chaudhuri, S. (2005) The WTO and India's Pharmaceuticals Industry: Patent Protection, TRIPS and Developing Countries. New Delhi, India: Oxford University Press.
8. Chaudhuri, S. (2008) Indian Generic Companies, Affordability of Drugs and Local Production in Africa with Special Reference to Tanzania. Milton Keynes, UK: The Open University. IKD Working Paper No. 37, http://www.open.ac.uk/ikd/ documents/working-papers/ikd-workingpaper-37.pdf, accessed 10 March 2010.
9. Costello, M.J. (1994) Market and state: Evaluating Tanzania's program of state-led industrialization. World Development 22(10): 1511-1520.
10. Diyamett, B.D. and Wangwe, S.M. (2001) Innovation indicators within sub-Saharan Africa: Usefulness, methodologies and approaches: A specific case for Tanzania. Paper presented at the DACST/OECD Seminar on Innovation Measurement in OECD and Non-OECD Countries; 28-29 March 2001, Pretoria.
11. Evans, P. (1996) Embedded Autonomy: States and Industrial Transformation. Princeton, NJ: Princeton University Press.
12. Guimer, J-M., Lee, E. and Grupper, M. (2004) Processes and Issues for Improving Access to Medicines: The Evidence Base for Domestic Production and Greater Access to Medicines. London: DFID Health Systems Resource Centre.
13. Kaplan, W. and Laing, R. (2005) Local Production of Pharmaceuticals: Industrial Policy and Access to Medicines: An Overview of Key Concepts, Issues and Opportunities for Future Research. Washington DC: World Bank. Health, Nutrition and Population (HNP) Discussion Paper.
14. Kitua, A. (2007) Health research agenda for East Africa in the new millennium: Looking ahead. Tanzania Health Research Bulletin 9(3): 147-153.
15. Losse, K., Schneider, E. and Spennemann, C. (2007) The Viability of Local Production in Tanzania. Eschborn, Germany: Deutsche Gesellschaft fur.
16. Mani, S. (2002) Government, Innovation and Technology Policy: An International Comparative Analysis. Cheltenham, UK: Edward Elgar.
17. Ministry of Health. (1993) A Short Information Manual on the National Drug Policy, the Masterplan for Pharmaceutical Sector 1992-2000 Tanzania Mainland: A Summary. Dar es Salaam, Tanzania: Ministry of Health.
18. Ministry of Health & Social Welfare. (2006) Strategies for promotion of local production of pharmaceuticals in Tanzania-2006-2016: Draft proposal. Dar es Salaam, Tanzania, Ministry of Health & Social Welfare, August.
19. Médicins sans Frontières (MSF). (2008) Untangling the Web of Antiretroviral Price Reductions, 11th edn., July, http://www. doctorswithoutborders.org/publications/article.cfm?id=3728&cat= specialreport, accessed 20 October 2009.
20. Mwalimu, U.A. (2003) The Implications of WTO Agreement on Trade-related Aspects of Intellectual Property Rights (TRIPS) in Tanzania: A Focus on Pharmaceuticals. Dar es Salaam, Tanzania: Economic and Social Research Foundation. ESRF Working Paper Series No. 4.
21. Pack, H. and Saggi, K. (2006) The Case for Industrial Policy: A Critical Survey. Washington: World Bank (February). World Bank Policy Research Working Paper 3839.
22. Rodrik, D. (2004) Industrial Policy for the Twenty First Century. London: CEPR (November). CEPR Discussion Paper No. 4767.
23. Rovira, J. (2006) Creating and promoting domestic drug manufacturing capacities. In: P. Roffe, G. Tansey and D. Vivas-Eugui (eds.) Negotiating Health: Intellectual Property and Access to Medicines. London: Earthscan.
24. Shadlen, K. (2007) The political economy of AIDS treatment: Intellectual property and the transformation of generic supply. International Studies Quarterly 51: 559-581.
25. Shelys Pharmaceuticals. (2008) Company Profile. Dar es Salaam, Tanzania: Shelys Pharmaceuticals.
26. UNCTAD. (2006) Trade and Development Report. Geneva, Switzerland: UNCTAD.
27. Wangwe, S. (2003) African systems of innovation: Towards an interpretation of the development experience. Revised version of paper presented at the International Workshop on African Systems of Innovation and Competence-building in the Era of Globalization; March 2001, Denmark: University of Aalborg.
28. World Health Organization (WHO). (2004) The World Medicines Situation. Geneva, Switzerland: WHO.
29. World Health Organization (WHO). (2005) Local Production of Essential Medicines, Including Antiretrovirals: Issues, Challenges and Perspectives in the African Region. Report of the Regional Director, Regional Committee for Africa, Fifty-fifth Session, Maputo, Mozambique, 22-26 August.
30. World Health Organization/Health Action International (WHO/HAI). (2003) Medicines prices: A new approach to measurement, http://www.haiweb.org, downloaded 25 September 2006.